Compounds > n-methyl-3,4-methylenedioxyamphetamine

n-methyl-3,4-methylenedioxyamphetamine and oxymetazoline

n-methyl-3,4-methylenedioxyamphetamine has been researched along with oxymetazoline in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Docherty, JR; Lavelle, A; Leong, S; Rajamani, K1
de Venecia, G; Michael, JC; Pak, J; Pulido, J1

Other Studies

2 other study(ies) available for n-methyl-3,4-methylenedioxyamphetamine and oxymetazoline

ArticleYear
Prejunctional actions of methylenedioxymethamphetamine in vas deferens from wild-type and alpha(2A/D)-adrenoceptor knockout mice.
    European journal of pharmacology, 2001, Jul-06, Volume: 423, Issue:2-3

    Topics: Adrenergic Agents; Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Animals; Desipramine; Dose-Response Relationship, Drug; Electric Stimulation; Female; Genotype; Heart Atria; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle Contraction; N-Methyl-3,4-methylenedioxyamphetamine; Neuromuscular Junction; Nifedipine; Norepinephrine; Oxymetazoline; Receptors, Adrenergic, alpha-2; Tritium; Vas Deferens; Vasodilator Agents; Xylazine

2001
Central serous chorioretinopathy associated with administration of sympathomimetic agents.
    American journal of ophthalmology, 2003, Volume: 136, Issue:1

    Topics: Adult; Choroid Diseases; Ephedrine; Female; Fluorescein Angiography; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Ophthalmoscopy; Oxymetazoline; Retinal Diseases; Sympathomimetics; Visual Acuity

2003